Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial

Rasha Al-Lamee et al. · PI Justin E Davies, MRCP, PhD

Primary endpoint

Exercise Time on Treadmill

Population

Stable Angina; n=230

doi:10.1016/S0140-6736(17)32714-9

Historical

Current

Future

3 noemes

Historical

1 noeme

Published findings from this trial. Vote whether the expert body still believes each noeme stands given current evidence.

The ORBITA trial's stated primary conclusion — PCI does not improve exercise time vs. a sham procedure in stable single-vessel coronary disease. — replicates in independent cohorts.

cardiology

Current

1 noeme

Noemes tracking active replication, subgroup analysis, or long-term follow-up. Vote on the likelihood the original effect holds.

Recent follow-up analyses of ORBITA are confirming the original effect size in real-world data.

cardiology

Future

1 noeme

Open forecast horizons tied to this trial. Vote your probability that each resolves TRUE by the declared horizon.

By 2028, sham-controlled trials (ORBITA-2 and successors) will define reimbursement criteria for elective PCI in stable CAD.

cardiology

71%

Semantically related trials

Nearest trials by noeme-centroid cosine distance. Lower = closer.

NCT01471522

0.1229

· 3 claims

Initial Invasive or Conservative Strategy for Stable Coronary Disease

NCT01692379

0.1766

· 3 claims

Thrombectomy within 8 Hours after Symptom Onset in Ischemic Stroke

NCT01804355

0.1842

· 3 claims

A Randomized Trial of Intraarterial Treatment for Acute Ischemic Stroke

NCT02586415

0.1908

· 3 claims

Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion Imaging

NCT01778335

0.1916

· 3 claims

Randomized Assessment of Rapid Endovascular Treatment of Ischemic Stroke

NCT01657461

0.1979

· 3 claims

Stent-Retriever Thrombectomy after Intravenous t-PA vs. t-PA Alone in Stroke